The First Beijing International Medical Forum on Precision Medicine and Cancer Treatment

(Yanqi Lake, 2016)

Time: June 15-17, 2016

Venue: International Conference Center, University of Chinese Academy of Sciences

Forum Introduction:

Recently, the early diagnosis and early treatment of cancer is becoming possible with a variety of new theories and new methods emerging. To fully implement the "National long-term Science and Technology Development Plan (2006-2020)," to further strengthen the international academic and medical exchanges for precision cancer treatment, to promote accurate medical disciplinary research, and to enhance China's technological innovation and development, the first Beijing International Medical Forum on Precision Medicine and Cancer Treatment will be hold during June 16-18, 2016 by the Chinese Medical Association and University of Chinese Academy of Sciences. The conference will focus on high frequent incidence of malignant tumors, basing on large-scale clinical specimens, associating with genomics, proteomics, immunohistochemistry and metabolomics. The purpose is to expand our know-how to find more accurate diagnosis and precise treatments.


  • Precision Medicine and Cancer Treatment
  • Tumor Immunotherapy
  • Immunotherapy on the Horizon
  • GWAS (Genome wide associated study) 
  • Proteomics and diseases
  • Metabolomics and diseases

Forum Purpose

Speakers are leading authorities in tumor immunology and cancer immunotherapy, bioinformatics and clinical oncologists. The talks will facilitate understanding:

1) The basic principles of tumor immunology and immunotherapy;

2) The clinical indications for immunotherapy and the appropriate selection and management of patients;

3) Emerging concepts and agents in the cancer immunotherapy field;

4) The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes. 

Planning Speakers (June 16-17, 2016)

  1. Qimin ZHAN: Professor and Academician,President of Peking University Health Science Center

“Precision Medicine and Cancer Treatment”

  1. Christopher Conlon: Professor, Head of Nuffield Department of Medicine, University of Oxford, United Kingdom

“Medical Education in the 21st Century”

  1. Zihe RAO: Professor and Academician, School of Medicine, Tsinghua University
  2. Andrew McMichael: Professor, Nuffield Department of Medicine, University of Oxford, United Kingdom

“Fighting HIV with T cells”

  1. Huanming YANG: Academician & Chair of Board, BGI Shenzhen

“From the HGP to “Precision Medicine”

  1. Brad St. Croix: NIH, USA

“Targeting the Tumor Microenvironment with Antibody Drug Conjugates”

  1. Guoqiang CHEN: Professor and Academician, PhD, Shanghai Jiao Tong University School of Medicine

“Application of chemical biology in understanding leukemic cell fate determination”

  1. Jizong ZHAO: Professor and Academician, PhD, Beijing Tiantan Hospital, Capital Medical University

“Precision Medical research is another way of glioma”

  1. Joseph Jonkers: Professor of Molecular Experimental Oncogenetics and Cancer Therapeutics. Head of Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

“Genetic dissection of breast cancer development, therapy response and resistance in mouse models”

  1. Xiyun YAN: Professor and Academician, Ph.D,Institute of Biophysics, Chinese Academy of Sciences

“Tumor new target discovery, characterization and application

  1. Anne-Maria Pajari:Professor, Group leader, Department of Food and Environmental Sciences, University of Helsinki, Finland

“Multiple mechanisms of berries in preventing cancer cell growth and migration”

  1. Reedik Mägi: PhD, head of Bioinformatics Unit, Estonian Genome Center, University of Tartu, Estonia

“Piloting personalized medicine in Estonia: Breast cancer risk assessment as a model of genomic medicine”

  1. Rebecca A. Miksad: MD, MPH, Professor of Dana-Farber/Harvard Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts General Hospital, Boston, USA

“Precision medicine in hepatocellular carcinoma: strategies and outcomes”

  1. Fusheng WANG: Professor and Academician, MD, PhD, 302 Military Hospital of China.

“Immunotherapy of hepatocellular carcinoma and HBV”

  1. Chun YUAN: Professor, Ph.D., Vascular Imaging Laboratory, University of Washington, USA

“Novel imaging modalities for the diagnosis of carotid artery disease”


Forum Organizers:

Savaid Medical School, University of Chinese Academy of Sciences

Chinese Medical Association

Beijing Huairou Hospital, University of Chinese Academy of Sciences

Secretaries: Dr.Liangqi WU; Dr.Likui WANG

Tel: +86-10-6967 2481;  +86-10-6967 2488   Email: